These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

785 related articles for article (PubMed ID: 8196360)

  • 1. Experimental IgA nephropathy. Enhanced deposition of glomerular IgA immune complex in proteinuric states.
    Chen A; Ding SL; Sheu LF; Song YB; Shieh SD; Shaio MF; Chou WY; Ho YS
    Lab Invest; 1994 May; 70(5):639-47. PubMed ID: 8196360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen as mediator of glomerular injury in experimental IgA nephropathy.
    Montinaro V; Esparza AR; Cavallo T; Rifai A
    Lab Invest; 1991 Apr; 64(4):508-19. PubMed ID: 2016857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monomeric immunoglobulin A protects glomerulus against polymeric immunoglobulin A immune complex in experimental immunoglobulin A nephropathy.
    Chen A; Sheu LF; Ding SL; Lee WH
    Lab Invest; 1996 Apr; 74(4):737-46. PubMed ID: 8606484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-idiotype antibody directly interferes with glomerular IgA immune complex deposition.
    Chen A; Sheu LF; Shaio MF; Huang TH; Ding SL; Lee WH
    Nephron; 1998; 78(4):464-73. PubMed ID: 9578073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of mesangial complement in the hematuria of experimental IgA nephropathy.
    Emancipator SN; Ovary Z; Lamm ME
    Lab Invest; 1987 Sep; 57(3):269-76. PubMed ID: 3306149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of renal injury in a chronic model of IgA immune-complex-associated nephropathy.
    Montinaro V; Aventaggiato L; Cavallo T; Rifai A
    Nephrol Dial Transplant; 1995 Nov; 10(11):2035-42. PubMed ID: 8643164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-macrophage migration inhibitory factor reduces transforming growth factor-beta 1 expression in experimental IgA nephropathy.
    Leung JC; Chan LY; Tsang AW; Liu EW; Lam MF; Tang SC; Lai KN
    Nephrol Dial Transplant; 2004 Aug; 19(8):1976-85. PubMed ID: 15187193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glomerular localization of nephritogenic protein complexes on a nonimmunologic basis.
    Chen A; Chou WY; Ding SL; Shaio MF
    Lab Invest; 1992 Aug; 67(2):175-85. PubMed ID: 1501444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and characterization of circulating and glomerular immune complexes in experimental IgA nephropathy.
    González-Cabrero J; Egido J; Barat A; González E
    Immunology; 1990 Jul; 70(3):296-302. PubMed ID: 2379938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement depletion abolishes IgA-mediated glomerular inflammation in rats.
    Stad RK; van Gijlswijk-Janssen DJ; van Es LA; Daha MR
    Exp Nephrol; 1994; 2(3):182-9. PubMed ID: 7922271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of circulating idiotypes containing immune complexes and their presence in the glomerular mesangium in patients with IgA nephropathy.
    González-Cabrero J; Egido J; Mampaso F; Rivas MC; Hernando L
    Clin Exp Immunol; 1989 May; 76(2):204-9. PubMed ID: 2667819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement activation in experimental IgA nephropathy: an antigen-mediated process.
    Rifai A; Chen A; Imai H
    Kidney Int; 1987 Dec; 32(6):838-44. PubMed ID: 3430967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrarenal cytokines modulate the glomerular response to IgA immune complexes.
    Montinaro V; Hevey K; Aventaggiato L; Fadden K; Esparza A; Chen A; Finbloom DS; Rifai A
    Kidney Int; 1992 Aug; 42(2):341-53. PubMed ID: 1405317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uteroglobin is essential in preventing immunoglobulin A nephropathy in mice.
    Zheng F; Kundu GC; Zhang Z; Ward J; DeMayo F; Mukherjee AB
    Nat Med; 1999 Sep; 5(9):1018-25. PubMed ID: 10470078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatial arrangement of IgA and C3 as a prognostic indicator of IgA nephropathy.
    Muda AO; Feriozzi S; Rahimi S; Faraggiana T
    J Pathol; 1995 Oct; 177(2):201-8. PubMed ID: 7490687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective hepatic handling of IgA immune aggregates by mice with experimental IgA nephropathy.
    González E; González-Cabrero J; Egido J
    Immunology; 1989 Jul; 67(3):308-13. PubMed ID: 2759657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymolysis of glomerular immune deposits in vivo with dextranase/protease ameliorates proteinuria, hematuria, and mesangial proliferation in murine experimental IgA nephropathy.
    Gesualdo L; Ricanati S; Hassan MO; Emancipator SN; Lamm ME
    J Clin Invest; 1990 Sep; 86(3):715-22. PubMed ID: 2203821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective oral tolerance promotes nephritogenesis in experimental IgA nephropathy induced by oral immunization.
    Gesualdo L; Lamm ME; Emancipator SN
    J Immunol; 1990 Dec; 145(11):3684-91. PubMed ID: 1700991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of antioxidant enzyme activities in renal tissues of early stage IgA nephropathy in ddY mice.
    Wang LN; Fukui M; Shou I; Yaguchi Y; Funabiki K; Horikoshi S; Shirato I; Tomino Y
    J Clin Lab Anal; 1996; 10(6):394-8. PubMed ID: 8951608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgA nephropathy in adults: immunohistologic findings and clinical course.
    Parai SK; Ghose T
    Can Med Assoc J; 1985 Jun; 132(12):1381-4. PubMed ID: 3891058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.